Stories

The first six months of 2025 have been exceptional for Ipsen. We’ve delivered strong growth across all three of our therapeutic areas — Rare Disease, Oncology, and Neuroscience — reflecting the strength of our strategy and the dedication of our teams. 

Joris is a thriving seven-and-a-half-year-old boy who has been on a journey requiring strength and hope from himself, and all those around him. At just four weeks old, Joris began exhibiting unusual symptoms; vomiting, changes in his eating habits and he had very pale poo.

Ipsen’s financial results for the first half of 2025 will be published on 31 July 2025 at 07:00 CET.

At just nine years old, Suzanne is a bright, creative young girl who loves dancing, drawing, exploring the woods, and watching birds. Despite living with Alagille syndrome (ALGS), a rare genetic condition, she embraces life with enthusiasm and curiosity.

A replay with complete presentation and Q&A session will be made available soon after the Annual General Meeting.